WallStreetZenWallStreetZen

NASDAQ: GRCE
Grace Therapeutics Inc Earnings Dates, Reports, Calls

Grace Therapeutics earnings were -$11.4M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest GRCE earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$2.6M, down 17.3% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, GRCE reported annual earnings of -$12.9M, with -69.7% growth. The next GRCE earnings date is Nov 11, 2024.

GRCE earnings history

Current Revenue
$0.0
Current Earnings
-$11.4M
Current Profit Margin
0%

GRCE Return on Equity

Current Company
-18.1%
Current Industry
22.8%
Current Market
33.7%
GRCE's Return on Equity (-18.1%)... subscribe to Premium to read more.
High Return on Equity Performance

GRCE Return on Assets

Current Company
-15.4%
Current Industry
3.5%
GRCE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GRCE announces earnings.

GRCE Return on Capital Employed

Current Company
-21.62%
Current Industry
21.3%
GRCE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GRCE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GRCE-$14.51M-$11.45MN/A-$1.14
MRKR-$10.37M-$10.37MN/A-$1.18
ANTX-$64.64M-$64.66MN/A-$2.21
PMN-$11.95M-$12.20MN/A-$0.60
LGVN-$17.66M-$27.90MN/A-$8.74

GRCE earnings dates

Next earnings date
Nov 11, 2024

Grace Therapeutics Earnings Reports & History FAQ

What were Grace Therapeutics's earnings last quarter?

On GRCE's earnings call on Invalid Date, Grace Therapeutics (NASDAQ: GRCE) reported Q2 2024 earnings per share (EPS) of -$0.24, up 55.56% year over year. Total GRCE earnings for the quarter were -$2.62 million. In the same quarter last year, Grace Therapeutics's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Grace Therapeutics stock.

When does Grace Therapeutics report earnings?

The next GRCE earnings call is Invalid Date. Add GRCE to your watchlist to be reminded of Grace Therapeutics's next earnings date.

Is Grace Therapeutics profitable or losing money?

As of the last Grace Therapeutics earnings report, Grace Therapeutics is currently losing money. Grace Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$11.45 million, a 72.7% decrease year over year.

What was GRCE's earnings growth in the past year?

As of Grace Therapeutics's earnings date in Invalid Date, Grace Therapeutics's earnings has grown year over year. GRCE earnings in the past year totalled -$11.45 million.

What are Grace Therapeutics's earnings expectations?

The current EPS estimate for Grace Therapeutics's earnings report in Invalid Date is -$0.45.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.